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During murine kidney development, canonical WNT signaling
is highly active in tubules until about embryonic days
E16–E18. At this time, b-catenin transcriptional activity is
progressively restricted to the nephrogenic zone. The cilial
protein genes PKD1 and PKD2 are known to be mutated in
autosomal dominant polycystic kidney disease (ADPKD), and
previous studies proposed that these mutations could lead to
a failure to suppress canonical WNT signaling activity. Several
in vitro studies have found a link between cilial signaling and
b-catenin regulation, suggesting that aberrant activity might
contribute to the cystic phenotype. To study this, we crossed
T-cell factor (TCF)/b-catenin-lacZ reporter mice with mice
having Pkd1 or Pkd2 mutations and found that there was
no b-galactosidase staining in cells lining the renal cysts.
Thus, suppression of canonical WNT activity, defined by the
TCF/b-catenin-lacZ reporter, is normal in these two different
models of polycystic kidney disease. Hence, excessive
b-catenin transcriptional activity may not contribute to
cystogenesis in these models of ADPKD.
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WNTs are secreted signaling molecules critical to many
developmental processes such as organogenesis, and their
aberrant activity is associated with a number of disorders
including diabetes and Alzheimer’s disease.1–3 In mammals,
19 different WNTs and 10 WNT receptors (Frizzleds) have
been discovered thus far. Dependent on the context of the cell
receiving a WNT signal, WNT molecules can be categorized
as canonical or noncanonical. When a canonical WNT binds
its cognate frizzled receptor with lipoprotein receptor-related
protein (LRP)5/6 co-receptor, the effector molecule b-catenin
is stabilized in the cytosol and translocates to the nucleus
where it binds T-cell factor (TCF)/lymphoid enhancer-
binding factor 1 (LEF1) to activate transcription of proli-
ferative genes such as c-myc.4,5 WNTs can also activate
b-catenin-independent (noncanonical) pathways that direct
the asymmetric localization of intracellular proteins involved
in determining cell shape, movement, and cytokinesis.6 Such
processes involve numerous effector molecules whose func-
tions remain less well understood, particularly in kidney
development.
In 2005, Simons et al.7 proposed that during normal
kidney development, the onset of urinary flow-dependent
cilial signals effects a switch from predominantly canonical to
noncanonical WNT signaling activity. That study suggested
that loss of genes involved in cilial signaling may lead to
failure of events initiated by noncanonical WNT pathways
and promote aberrant canonical WNT activity; either
scenario could contribute to a cystic kidney phenotype. In
support of the proposal that there is a developmental switch
between canonical and noncanonical WNT signaling path-
ways, Karner et al.8 showed that WNT9b is capable of
delivering a canonical message required for nephron induc-
tion and a later noncanonical signal involved in tubule
elongation.
During kidney development, intense canonical WNT
activity is normally associated with rapid proliferation,
branching morphogenesis of the ureteric bud (UB) tip, and
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the twisting morphogenesis of the emerging nephron.9,10
Thus, it is tempting to speculate that failure to suppress
canonical WNT signaling during tubular maturation may
account for the development of cysts in autosomal dominant
polycystic kidney disease (ADPKD). Indeed, a mouse model
with unregulated b-catenin activity develops a severe cystic
phenotype,11 and a number of studies have linked cilial
signaling to the downregulation of b-catenin activity.12–14
Based on these studies the current belief is that b-catenin
is not suppressed normally in ADPKD and is aberrantly
active in the epithelial cells lining cysts. However, Simons’
hypothesis also predicts a failure of noncanonical WNT
pathways activation. In order to develop new therapeutic
strategies for ADPKD, it is important to understand whether
aberrant canonical WNT signaling or faulty noncanonical
WNT signaling (or both) drive cystogenesis in ADPKD.
ADPKD is one of the most common monogenic disorders,
affecting 1 in 400 to 1 in 1000 individuals and is
characterized by the progressive development of bilateral
renal cysts that eventually reduce renal function.15 The
disease is caused by loss-of-function mutations in the PKD1
(polycystic kidney disease 1 (autosomal dominant)) or PKD2
(polycystic kidney disease 2 (autosomal dominant)) genes,
which encode the membrane proteins polycystin-1 and
polycystin-2, respectively.16 During kidney development in
individuals carrying a mutated allele of PKD1 or PKD2, it is
thought that some cells acquire second ‘hits’ to the wild-type
allele, resulting in an aberrant cell phenotype. If the aberrant
cell phenotype is because of ectopic b-catenin activity, then
inhibition of the canonical WNT pathway might provide an
effective therapeutic strategy.
In this study, we analyze the regulation of canonical WNT
activity in ADPKD. We begin by observing that in normal
mice, the infrastructure required for the developmental
switch is in place by E16. Specifically, primary cilia are
present on renal epithelial cells, the ureters have established
a patent connection with the bladder, and distension of
Bowman’s capsule are evidence indicating that glomerular
ultrafiltration has begun. To determine if b-catenin is
inappropriately active in ADPKD, we crossed a TCF/b-
catenin-lacZ reporter mouse, validated previously,17 to mice
with mutations in Pkd1 or Pkd2 and determined the
ontogeny of cyst formation relative to the normal develop-
mental downregulation of TCF/b-catenin transcriptional
activity.18
In homozygous Pkd1-null mice, cysts arose at E16 but
canonical WNT reporter activity was suppressed normally. As
Pkd1-null mice die in utero, we studied the hypermutable
Pkd2/WS25 mice, which are viable and develop cysts by
2 weeks of age.19 The TCF/b-catenin-lacZ reporter activity
was suppressed normally in the perinatal period. By 8 weeks
of age, renal cysts were widespread but no TCF/b-catenin-
lacZ reporter activity was observed. This study provides
direct evidence that b-catenin transcriptional activity, as
detected by the TCF/b-catenin-lacZ reporter, is unlikely to
contribute to cystogenesis in ADPKD.
RESULTS
Primary cilia on renal tubular cells appeared by E15 and were
present at the UB tips where b-catenin transcriptional activity
is high in wild-type mice
In order to determine appearance of cilial structures in the
developing kidney, frozen sections of wild-type kidneys
were stained for anti-a-tubulin and analyzed by immuno-
fluorescent histochemistry to visualize the primary cilia
on renal tubular cells. Cilia were first observed at E15
(Figure 1a–c). To confirm the presence of cilia, ultrathin
sections of wild-type kidneys from E15.5 embryos were
analyzed with transmission electron microscopy. Primary
cilia on renal epithelial cells including the basal bodies were
clearly visible at E15.5 (Figure 1d). At E18.5, scanning
electron microscopy (SEM) shows numerous primary cilia on
the luminal side of the renal tubular cells (Figure 1e).
The UB tips were clearly distinguishable in frozen sections
of E18.5 kidneys from a Hoxb7-GFP embryo (Figure 1f).
Staining for anti-a-tubulin on the same E18.5 sample showed
the presence of primary cilia at the UB tips (Figure 1g), which
is an area of the developing kidney that exhibits strong
TCF/b-catenin-lacZ reporter activity (Figure 1h).
By E16, the ureters have established a patent connection
with the bladder and glomerular distension is evident
The work of Simons et al.7 in vitro showed that renal tubular
flow could reduce levels of active b-catenin. We used Hoxb7-
GFP embryos and analyzed the time of contact between
ureters and the bladder, which is a requirement for the
initiation of renal tubular flow. The Hoxb7 (homeobox B7)
promoter is active in the UB lineage and its derivatives,
including the ureters,20 making the Hoxb7-GFP embryos
ideal for studying the migratory path of the ureters. Embryos
were microdissected and the green fluorescent protein
(GFP)-containing ureters were visualized by fluorescent
microscopy. By E15.5, the ureters had made a physical
connection with the bladder, providing the outlet for urinary
flow (Figure 2a). Tubular flow also requires an input
provided by glomerular ultrafiltration, which is associated
with distension of Bowman’s capsule. By E15.5, embryos had
numerous distended glomerular structures (Figure 2b). To
demonstrate patency at the ureterovesicular junction, we
microinjected E16 kidneys with Lissamine Green. The dye
entered the embryonic bladder and refluxed up the
contralateral ureter (Figure 2c and d).
TCF/b-catenin transcriptional activity was restricted normally
in homozygous Pkd1-null mutants
The TCF/b-catenin-lacZ reporter mouse demonstrates re-
striction of canonical WNT activity in the medulla while
maintaining intense b-catenin transcriptional activity in the
renal tubules of the nephrogenic zone beginning around E16
and continuing until the end of kidney development.18 In
order to characterize the pattern of canonical WNT signaling
activity in a cystic context, we crossed the TCF/b-catenin-
lacZ reporter mouse with a previously described Pkd1 cystic
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model.21 In these mutant mice, exons 2–4 were removed,
resulting in a functionally null allele. Homozygous mice do
not survive past E18 and develop kidney cysts.
Homozygous Pkd1 mutants bearing the TCF/b-catenin-lacZ
reporter lacked visible renal cysts at E15 but, by E16, cysts
were easily observed and by E17 cysts were widespread
throughout the renal cortex and medulla (Figure 3). As
previously reported, these mutant embryos do not survive to
E18; the ontogeny of cyst formation closely duplicated that of
previous studies.21 However, in the cystic kidneys, TCF/
b-catenin-lacZ reporter activity was not seen in the cells
lining the cysts, suggesting that no aberrant canonical WNT
signaling was present.
TCF/b-catenin transcriptional activity was not present in
postnatal cysts in Pkd2/WS25 mutants
The embryonic lethality of the homozygous Pkd1 mutants
did not allow the examination of b-catenin activity in
postnatal cysts. This led us to study the hypermutable
Pkd2/WS25 model of ADPKD19 in combination with the
TCF/b-catenin-lacZ reporter. The Pkd2 allele in these mice
contains a neomycin cassette inserted into the first exon of
the Pkd2 gene, which generates a premature stop codon and a
null allele.19 The WS25 allele carries a large duplication of the
50 region of the Pkd2 gene, which creates a highly unstable
gene structure capable of frequent somatic recombination to
produce a null allele.19 The Pkd2/WS25 mice bearing the lacZ
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Figure 2 |Conditions for urinary flow are present by E16.
(a) Side view of an E15.5 Hoxb7-GFP embryo showing a physical
connection between ureter and bladder. White arrowhead
indicates where ureter and bladder make contact. (b) A distended
glomerulus in the kidney of an E15.5 embryo (hematoxylin/eosin).
(c) Before and (d) after Lissamine Green microinjection of an E16
kidney shows the dye in the renal pelvis, ureter, embryonic
bladder, and contralateral ureter, demonstrating patency of
ureterovesicle junctions.
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Figure 1 |Ontogeny of primary cilia on renal epithelial cells.
(a–c) Representative frozen sections of embryonic kidneys stained
with anti-a-tubulin (red) show that cilia were absent at E13 and
E14 but were easily detected at E15. (d) Transmission electron
microscopy (TEM) confirmed the presence of primary cilia in E15.5
kidney samples. Basal body (bb) is indicated. Scale bar¼ 0.2mm.
(e) At E18.5, scanning electron microscopy (SEM) demonstrated
that the primary cilia project up to 12 mm into the lumen of the
renal tubules. (f) A ureteric bud (UB) tip at the perimeter of the
nephrogenic zone is identified by expression of a Hoxb7-GFP
transgene. (g) The same E18.5 tissue section was stained with
anti-a-tubulin antibody to identify cilia in the UB tip.
(h) Characteristic b-catenin-lacZ staining (blue) at E18.5; the
most intense reporter activity is seen in renal tubules in the
nephrogenic zone. White arrowheads indicate cilia.
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reporter developed one to two cysts around 2 weeks of age
and by 8 weeks of age the cysts were widespread (Figure 4).
In the mouse, nephrogenesis is complete around 2 weeks
after birth. Shortly after the kidney is fully developed,
TCF/b-catenin-lacZ reporter activity disappears, making this
an excellent reporter to study canonical WNT activity in
postnatal cystic kidneys. In 8-week-old Pkd2/WS25 mice
carrying the TCF/b-catenin reporter, kidneys were removed
and stained for b-galactosidase activity. No TCF/b-catenin-
lacZ reporter activity was observed in the cystic kidneys
(Figure 4), suggesting that canonical WNT signaling was not
active in the cysts of Pkd2/WS25 mice. We also performed
immunohistochemistry with an antibody to b-galactosidase
on sections of E16 and 2-week cystic kidneys. Strong
expression of the enzyme was evident at E16 in tips of the
arborizing UB, S-shaped body, and emerging tubules,
conforming to the pattern of TCF/b-catenin-lacZ reporter
activity (Figure 5a and b). No b-galactosidase immunostain-
ing was evident in renal tissue at 2 weeks (Figure 5c and d)
nor in E16 tissue from a mouse lacking the TCF/b-catenin-
lacZ reporter (not shown).
To further confirm our findings and corroborate the
sensitivity of the TCF/b-catenin-lacZ reporter mouse to detect
canonical WNT signaling activity, quantitative Western blots for
unphosphorylated (active) b-catenin were performed on tissue
lysates of E16 and 2-week kidneys (Figure 6). No significant
differences were observed in the amount of unphosphorylated
b-catenin found in wild-type kidneys compared with Pkd2/
WS25 kidneys.
DISCUSSION
At the onset of metanephric kidney development in the mouse,
robust canonical WNT signaling is evident throughout the
arborizing UB.18 Activation of TCF/LEF1/b-catenin gene targets
appears to be critical for cell proliferation and motility that
support branching at the UB tip; conditional knockout of
b-catenin in the UB leads to premature terminal differentiation
and cessation of branching.10,22 Canonical WNT signaling is also
seen in the early renal vesicle and S-shaped body, where it is
crucial for nephrogenesis;23 targeted inactivation of b-catenin in
the induced mesenchyme prevents the normal emergence of
nephrons.9,24 As kidney development proceeds, the activity of our
TCF/b-catenin transcription reporter becomes highly restricted.
The signal fades from cells of the maturing collecting duct trunk
but is sustained in outer UB tip cells where arborization
continues. In the emerging S-shaped body it is downregulated in
tubules as differentiation proceeds. By the early postnatal period,
canonical WNT signaling activity is confined to a narrow rim
where the final generations of nephrons are being formed;
residual pathway activity is not readily detectable in adult kidney.
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Figure 3 |Cyst ontogeny and b-catenin reporter activity in Pkd1 (polycystic kidney disease 1 (autosomal dominant)) homozygous
mutant embryos. Kidney sections from wild-type littermates at E15–E17 (top panel) illustrate the normal restriction of b-catenin activity to
the renal tubules of the cortical zone. Cysts were absent in embryos with homozygous mutations in Pkd1 at E15, but began to appear by
E16 and were widespread at E17 (middle panel). Despite the development of renal cysts in Pkd1-null embryos, b-catenin activity was
progressively restricted to the nephrogenic zone between E15 and E17, and no lacZ reporter activity was observed in cells lining ADPKD
cysts (bottom panel). Scale bars¼ 20 mm.
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Although canonical WNT signaling is crucial for the early
events that drive nephrogenesis, the pathway must be
downregulated for normal development to proceed. Trans-
genic mice with inappropriately sustained canonical WNT
signaling develop cystic renal dysplasia.11 In 2005, Simons
et al.7 proposed that canonical b-catenin signaling is
downregulated by the cilial protein, inversin. They showed
that inversin targets the signaling pathway molecule,
disheveled (DVL), for degradation. They also showed that
inversin activates separate noncanonical WNT signaling
pathways that are required for cell movement during
embryonic animal cap elongation and gastrulation. Finally,
they demonstrated that inversin expression is increased by
fluid movement over MDCK (Madin-Darby canine kidney)
cells in monolayer culture. Based on these observations, they
proposed that inversin might act as ‘a molecular switch
between different WNT signaling pathways’ and that onset of
tubular flow along the ciliated tubular epithelium might
provide the signal for normal downregulation of WNT
signaling during kidney development.7 Conversely, failure of
this mechanism might underlie the renal cystic phenotype.
In this study, we report that primary cilia are evident in
the renal tubular cells of wild-type mice by embryonic day
E15.5. At this point, the caudally migrating nephric duct has
penetrated the bladder wall, ultrafiltration has begun in some
maturing glomeruli, as evidenced by distension of Bowman’s
capsule, and patency at the ureteric orifice of the bladder was
confirmed at E16. These events are rapidly followed by
progressive loss of TCF/b-catenin-lacZ reporter activity
between E16 and E17. Thus, our observations define a
developmental window between E15 and E17 during which
flow-mediated cilial function may begin, in temporal
association with the suppression of canonical WNT signaling
downstream of functioning glomeruli. Interestingly, renal
development appears to progress normally in Pkd1-null
knockout mice until this point and renal cysts first appear at
about E16.
The molecular mechanisms that link cilial function to
downregulation of the canonical WNT pathway are complex,
but appear to converge on stabilization of cytoplasmic
b-catenin by reduced phosphorlyated DVL. Recently,
Kishimoto et al.25discovered that seahorse, a cilial protein
that binds to inversin, directly suppresses phosphorylation of
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Figure 4 |No aberrant b-catenin activity is observed in Pkd2/WS25 mice. Paraffin-embedded kidney sections from 2-week-old
Pkd2/WS25 embryos carrying the T-cell factor (TCF)/b-catenin-lacZ reporter show normal restriction of canonical WNT activity and a few
cysts (top panel). At 8 weeks of age, cysts are clearly visible in the Pkd2/WS25 kidneys but no b-catenin activity was observed
(bottom panel). Scale bars¼ 20 mm.
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Figure 5 | The pattern of immunohistochemical staining for
b-galactosidase conforms to the pattern of T-cell factor
(TCF)/b-catenin-lacZ reporter activity. Wild-type embryos
bearing the TCF/b-catenin-lacZ reporter were subjected to
immunohistochemistry for b-galactosidase (a) without and (b)
with the addition of the primary antibody at embryonic day E16.
Arrowheads show b-galactosidase in ureteric bud (UB) and
comma-shaped body. At 2 weeks of age, no immunostaining for
b-galactosidase was evident in the normal or cystic compartments
of Pkd2/WS25 kidneys. Representative images at original
magnifications of  10 (c) and  40 (a, b, d) are shown.
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DVL by casein II kinase-1; in the absence of phosphorylated
DVL, b-catenin undergoes proteasome-dependent degrada-
tion. Corbit et al.26 reported a similar effect of the cilial
protein, KIF3A (kinesin family member 3A), on DVL
phosphorylation. Gerdes et al.27 reported that the basal body
protein BBS4 (Bardet-Biedl syndrome 4) promotes protea-
some-dependent degradation of b-catenin itself. Taken
together, these observations have lent support to the
speculation that all human ciliopathies, including ADPKD,
might reflect a failure to suppress canonical WNT signaling.
Surprisingly, our observations show that TCF/b-catenin-lacZ
reporter activity is downregulated normally in the embryonic
kidneys of mice with homozygous inactivation of the Pkd1 gene.
At E17, Pkd1-null cyst cells are devoid of TCF/b-catenin-lacZ
reporter activity. Similarly, activity of the reporter transgene was
fully suppressed when tracked into the postnatal period in
Pkd2/WS25 mice. Canonical WNT signaling pathway activity
detected by the transgene was restricted to the thin nephrogenic
rim by two weeks of age and no ectopic canonical pathway
signal was seen at 8 weeks postnatal age. Although flow-
dependent cilial signals may suppress the b-catenin pathway, it
appears that polycystins are not required.
There are several lines of indirect evidence that prompted
the hypothesis that aberrant canonical WNT signaling might
drive cystogenesis in human polycystic kidney disease. Lal
et al.12 performed expression microarray analysis on cystic
tissue from ADPKD patients at the time of nephrectomy and
found an increase in b-catenin gene (CTNNB1) expression.
However, changes in b-catenin transcript level may easily be
secondary to chronic renal disease and do not necessarily
reflect nuclear signaling activity of the pathway. Kim et al.13
reported a modest increase in cellular b-catenin protein
in Pkd2 knockout mice, but immunohistochemistry for
b-catenin and c-MYC did not establish clear evidence for
increased nuclear levels of these proteins.
Our observations support those of Lancaster et al.,28 who
examined canonical WNT signaling with a TCF/b-catenin
reporter transgene in adult mice with knockout of the Ahi1
(Abelson helper integration site 1) gene, mutated in Joubert
Syndrome. Using a similar TCF/b-catenin-lacZ reporter
transgene, they demonstrated a low level of residual pathway
activity in adult kidney by increasing the sensitivity of
the standard b-galactosidase assay. However, in Ahi1-null
homozygotes, adult canonical WNT signaling was unexpect-
edly reduced in renal cysts following cisplatin administration.
In conclusion, this study supports the hypothesis by
Simons et al.7 that primary cilia may preside over a
developmental switch in WNT signaling pathways during
renal development. Our observations suggest a window
between E15 and E17 during which primary cilia appear on
renal epithelial cells, tubular flow begins, and canonical WNT
signaling is progressively restricted in maturing segments of
the nephron downstream of functional glomeruli. In mice
with homozygous inactivation of Pkd1 or Pkd2 genes, renal
development appears to proceed normally until the devel-
opmental transition at E15 and E16, but tubular cysts arise
thereafter. Surprisingly, however, developmental downregula-
tion of canonical WNT signaling appears to be normal
and we could find no evidence of aberrant TCF/b-catenin
transcriptional activity that could contribute to the cystic
phenotype. On the other hand, if ADPKD involves a failure
of the developmental switch in WNT signaling pathways, as
proposed by Simons et al.,7 then the possibility remains that
cystogenesis may be driven primarily by failure of polycystin-
dependent activation of noncanonical WNT signaling.
MATERIALS AND METHODS
Immunofluorescent histochemistry
C3H embryonic kidneys from stages E13 to E18.5 were fixed
overnight at 4 1C in 4% paraformaldehyde and embedded in optimal
cutting temperature (Sakura Finetek USA, Torrance, CA) and
frozen. Sections (12 mm) were washed in 1 phosphate-buffered
saline (PBS), fixed in cold acetone for 10 min at room temperature,
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Figure 6 |Quantitative western blotting for active b-catenin
shows no difference between wild-type (WT) and Pkd2/WS25
kidneys. Western blots for active b-catenin were performed on
tissue lysates from (a) E16 and (b) 2-week-old kidneys.
Quantification relative to actin demonstrates no change in the
levels of active b-catenin among the different genotype groups.
M, marker.
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air dried for 30 min, and washed with 1 PBS. Sections were
blocked with MOM mouse IgG blocking reagent and universal
blocking serum (Vector Laboratories, Burlingame, CA) for 1 h at
room temperature followed by incubation with monoclonal anti-
acetylated tubulin antibody (Sigma, Oakville, Canada) at 1:800
overnight at 4 1C. After three washes with 1 PBS, sections were
incubated with anti-mouse IgG (1:50) antibody (Sigma) for 1 h at
room temperature and washed three times in 1 PBS.
Transmission electron microscopy and SEM
For transmission electron microscopy, C3H embryonic kidneys were
fixed overnight in 2.5% glutaraldehyde/0.1 mol/l sodium cacodylate
buffer at 4 1C and washed three times in 0.1 mol/l cacodylate
buffer for 10 min at 4 1C. After that, tissues were osmicated in
1% OsO4/1.5% KfeCN for 2 h at 4 1C. Tissue samples were then
dehydrated with increasing percentages of acetone and infiltrated
with solutions of varying ratios of acetone/epon. The samples were
embedded in epon at 58 1C for 48 h. Ultrathin sections (80 nm) were
visualized with a JEOL JEM 2000 FXII transmission electron
microscope (JEOL, Tokyo, Japan).
For SEM, samples were fixed in 3% glutaraldehyde. The samples were
dehydrated and examined with a Hitachi field emission gun SEM (FE-
SEM S-4700, Hitachi High Technologies America, Pleasanton, CA).
Visualization of ureter–bladder connection
C3H mice bearing a GFP transgene under the control of the Hoxb7
promoter have been described elsewhere.20 Timed crossings of the
Hoxb7-GFP mice were done to generate embryos that underwent
microdissection to visualize the location of the ureters relative to the
bladder as performed previously.29
Microinjection of Lissamine Green into E16 kidneys
Kidneys of C3H E16 embryos were microinjected with 3% Lissa-
mine Green (Sigma-Aldrich, St Louis, MO) as described elsewhere.29
Generation of cystic mouse models
CD1 mice bearing a b-catenin-responsive lacZ reporter gene have been
previously described.17 Briefly, this transgene contains six TCF/LEF
response elements cloned upstream of a minimal Hsp68 promoter
driving the lacZ reporter gene. The b-catenin reporter mice were crossed
to Sv129 mice heterozygous for a deletion of exons 2 through 4 in the
Pkd1 gene, which results in a functionally null allele as described
elsewhere.21 An F1 intercross of hybrid mice carrying both the b-catenin
reporter and Pkd1 deletion was performed to generate reporter bearing
embryos homozygous for the Pkd1 mutation.
In parallel, the b-catenin reporter CD1 mice were also crossed to
C57BL6 mice harboring the WS25 hypomorphic allele of the Pkd2
gene. Hybrid mice heterozygous for both the lacZ reporter and
WS25 allele were backcrossed to C57BL6 mice bearing a Pkd2-null
allele to generate animals with the b-catenin reporter and both
mutant alleles of Pkd2. The Pkd2/WS25 model has been described
previously.19 Animal procedures followed the guidelines established
by the Canadian Council of Animal Care and were approved by the
Animal Care Committee from McGill University.
b-Galactosidase activity in kidney sections from embryonic
and postnatal mice with ADPKD
The protocol for b-galactosidase staining has been described
elsewhere.30 Following the staining procedure, kidneys were
embedded in paraffin, sectioned (6mm), and counterstained with
hematoxylin/eosin.
Immunohistochemistry for b-galactosidase on sections
of E16 and P14 kidneys
Kidneys from P15 Pkd2/WS25 animals and control littermates
bearing the TCF/b-catenin-lacZ reporter were fixed in 4%
paraformaldehyde overnight at 4 1C embedded in paraffin, and cut
into 6 mm sections. Tissue sections were de-paraffinized in xylene
and rehydrated by ethanol series. Sections were quenched with 3%
hydrogen peroxide in methanol for 30 min and washed in 1 PBS
for 5 min. Blocking was performed with horse serum from the
Vectastain Universal Elite ABC Kit (Vector Laboratories) at room
temperature for 30 min. The tissues were incubated in anti-
b-galactosidase antibody (Promega, Madison, WI) at 1:25 overnight
at 4 1C in a humidified chamber. The biotinylated secondary antibody
solution was applied at 1:500 followed by incubation in the ABC Mix
for 30 min each, at room temperature. The tissues were exposed to
peroxidase substrate solution for a maximum of 2 min, or until color
development was evident. Sections were counterstained with Gill’s
Hematoxylin (Electron Microscopy Sciences, Hatfield, PA) for 20 s
followed by vigorous washing with tap water until stain was completely
removed, and tissues were dehydrated by ethanol series.
Western blot of E16 and P14 Pkd2/WS25 kidney lysates for
unphosphorylated b-catenin
Kidneys from E16 and P15 Pkd2/WS25 animals and control
littermates were homogenized in cold hypotonic swelling buffer
(10 mmol/l Tris-HCl (pH¼ 7.4), 10 mmol/l NaCl, 3 mmol/l MgCl2,
protease inhibitor cocktail (F. Hoffmann-La Roche, Quebec,
Canada)) and left for 20 min on ice. NP40 (Roche Diagnostics,
Quebec, Canada) was added to a final proportion of 10% and the
lysates were centrifuged at 13,000 r.p.m. for 1 min at 4 1C The
supernatant was removed and the pellet was resuspended in cold
lysis buffer (20 mmol/l HEPES, 600 mmol/l KCl, 0.2 mmol/l EDTA,
protease inhibitor cocktail) and incubated on ice for 20 min.
Suspensions were centrifuged at 13,000 r.p.m. for 10 min at 4 1C.
Western blots were performed with 30mg protein from tissue extracts
from the Pkd2/WS25 and wild-type kidneys using the anti-active
b-catenin (anti-ABC), clone 8E7 antibody (Millipore, Billerica, MA)
at 1:500 with the secondary anti-mouse IgG horseradish peroxidase
(HRP)-linked antibody (Cell Signaling Technology, Danvers, MA) at
1:2000. The blots were stripped to allow quantification of unphos-
phorylated b-catenin relative to the housekeeping protein actin
with the anti-actin (Ab-1) mouse mAb (JLA20) antibody (EMD
Chemicals, Darmstadt, Germany) at 1:3000 with the secondary anti-
mouse IgM/HRP conjugate antibody (Stressgen Bioreagents,
British Columbia, Canada) at 1:2000. Band intensity was measured
using the ImageQuant TL v2003.02 software (GE Healthcare, Baie
d’Urfe, QC) and ratios of b-catenin to actin were determined.
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